June, 8-11, 2020 – Bicoll exhibits under the roof of German Pavilion at Bio International Convention 2020 in San Diego.
Bicoll owns small molecule, property-based isolation technologies to identify beneficial compounds (Bifrac N™ and Bipreselect™). These technologies turn plant extracts into promising sets of small molecules, so-called plant “Profiles™”. Therefore, the client selects the compounds and assembles them according to own test system. Moreover, they are fully compatible with HTS and cell based assay systems.
Proprietary in-house technology platform supports further innovative strategies. Bicoll is able to rapidly select only the best leads with superior drug-like profiles for the further development cycles. Subsequent medicinal chemistry and custom synthesis complete Bicoll profile. It offers seamless substantial services for the global pharmaceutical and biotech industries. Bicoll provides an efficient, multi-disciplinary approach to drug discovery. Thus, Bicoll dedicates itself to the discovery and optimization of the highest quality lead compounds. Read more here.
The BIO International Convention attracts 17,000+ biotechnology and pharma leaders. They come together for one week of intensive networking to discover new opportunities and promising partnerships. Wide spectrum includes life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
The full event program you may find here: https://www.bio.org/events/bio-international-convention/schedule-overview
